Vasopressors for the treatment of septic shock: Systematic review and meta-analysis.
Open accessThe DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: International guidelines recommend dopamine or norepinephrine as first-line vasopressor agents in septic shock. Phenylephrine, epinephrine, vasopressin and terlipressin are considered second-line agents. Our objective was to assess the evidence for the efficiency and safety of all vasopressors in septic shock. METHODS: Systematic review and meta-analysis. We searched electronic database of MEDLINE, CENTRAL, LILACS and conference proceedings up to June 2014. We included randomized controlled trials comparing different vasopressors for the treatment of adult patients with septic shock. Primary outcome was all-cause mortality. Other clinical and hemodynamic measurements were extracted as secondary outcomes. Risk ratios (RR) and mean differences with 95% confidence intervals (CI) were pooled. RESULTS: Thirty-two trials (3,544 patients) were included. Compared to dopamine (866 patients, 450 events), norepinephrine (832 patients, 376 events) was associated with decreased all-cause mortality, RR 0.89 (95% CI 0.81-0.98), corresponding to an absolute risk reduction of 11% and number needed to treat of 9. Norepinephrine was associated with lower risk for major adverse events and cardiac arrhythmias compared to dopamine. No other mortality benefit was demonstrated for the comparisons of norepinephrine to epinephrine, phenylephrine and vasopressin / terlipressin. Hemodynamic data were similar between the different vasopressors, with some advantage for norepinephrine in central venous pressure, urinary output and blood lactate levels. CONCLUSIONS: Evidence suggests a survival benefit, better hemodynamic profile and reduced adverse events rate for norepinephrine over dopamine. Norepinephrine should be regarded as the first line vasopressor in the treatment of septic shock.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures




Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“In the absence of septic shock or fungemia, some implanted tunneled catheter infections may be treated effectively with prolonged antimicrobial therapy if removal of the catheter is not practical (273).”
From Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2021. (2021) · cites this paper as [273]
Experimental — accuracy not yet measuredIn the citing paper
“In a systematic review and meta-analysis of 11 RCTs, norepinephrine resulted in a lower mortality (RR 0.89; 95% CI 0.81–0.98) and lower risk of arrhythmias (RR 0.48; 95% CI 0.40–0.58) compared with dopamine [347].”
From Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021 (2021) · cites this paper as [347]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bone, R. C., Balk, R. A., Cerra, F. B., Dellinger, R. P., Fein, A. M., Knaus, W. A., Schein, R. M. H., & Sibbald, W. J. (1992) · Chest · doi:10.1378/chest.101.6.1644 · Cited by 13,198
Early goal-directed therapy in the treatment of severe sepsis and septic shock
Rivers, E., Nguyen, B., Havstad, S., Ressler, J., Muzzin, A., Knoblich, B., Peterson, E., & Tomlanovich, M. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa010307 · Cited by 10,743 · cited 1×
“5 ml/kg/hr within 6 hours of initiation of therapy [5].”
BackgroundEstimating the mean and variance from the median, range, and the size of a sample
Hozo, S. P., Djulbegovic, B., & Hozo, I. (2005) · BMC Medical Research Methodology · doi:10.1186/1471-2288-5-13 · Cited by 9,062
Angus, D. C., Linde-Zwirble, W. T., Lidicker, J., Clermont, G., Carcillo, J., & Pinsky, M. R. (2001) · Critical Care Medicine · doi:10.1097/00003246-200107000-00002 · Cited by 8,503 · cited 1×
“Septic shock accounts for about 9% of admissions, and is the most common cause of death in intensive care units (ICUs) [1,2].”
BackgroundSurviving Sepsis Campaign guidelines for management of severe sepsis and septic shock
Dellinger, R. P., Carlet, J. M., Masur, H., Gerlach, H., Calandra, T., Cohen, J., Gea-Banacloche, J., Keh, D., Marshall, J. C., Parker, M. M., et al. (2004) · Intensive Care Medicine · doi:10.1007/s00134-004-2210-z · Cited by 3,321
Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock
Dellinger, R. P., Carlet, J. M., Masur, H., Gerlach, H., Calandra, T., Cohen, J., Gea-Banacloche, J., Keh, D., Marshall, J. C., Parker, M. M., et al. (2004) · Critical Care Medicine · doi:10.1097/01.ccm.0000117317.18092.e4 · Cited by 3,018 · cited 2×
“The Surviving Sepsis Campaign recommends norepinephrine or dopamine as the first-choice vasopressor agent followed by epinephrine in patients who respond poorly to dopamine or norepinephrine [7,8].”
BackgroundA randomized trial of protocol-based care for early septic shock.
The ProCESS Investigators (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1401602 · Cited by 2,414 · cited 6×
“The concept of early goal directed therapy was challenged recently in a large RCT [43], in which no mortality benefit with protocol based resuscitation was observed compared with usual care.”
BackgroundInfluentialComparison of Dopamine and Norepinephrine in the Treatment of Shock
De Backer, D., Biston, P., Devriendt, J., Madl, C., Chochrad, D., Aldecoa, C., Brasseur, A., Defrance, P., Gottignies, P., & Vincent, J.-L. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0907118 · Cited by 1,940 · cited 5×
“triple blinded [15], 8 trials were double blinded [13, 24, 26, 27, 30–32, 36], 2 were single blinded [20, 34] and the others were open-labeled or not stated.”
BackgroundResultInfluentialVasopressin versus Norepinephrine Infusion in Patients with Septic Shock
Russell, J. A., Walley, K. R., Singer, J., Gordon, A. C., Hébert, P. C., Cooper, D. J., Holmes, C. L., Mehta, S., Granton, J. T., Storms, M. M., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa067373 · Cited by 1,924 · cited 1×
“Study ID Sequence generation Allocation concealment Blinding Ethical committee / informed consent ITT analysis of primary outcome Incomplete data reporting Valid definition of septic shock Agrawal 2011 [11] Unclear Unclear Open Yes / Yes Yes Unclear Yes Albanese 2005 [12] Low Unclear Open Yes / Yes Yes Unclear Yes Ann…”
Research works printed but not linked: 3
- Chen H, Zeng Z (2012) Comparisom of the effect and complication between dopaimne and norepinephrine on treatment of the septic shock. Jiangxi Medical Journal 47: 565– 567.
- High K (2008) Impact of Dopamine and norepinephrine on renal perfusion in patients with septic shock. Journal of Hebei Medicine 30: 1188– 1121.
- Zhuangyu Y (2011) Affect of norepinephrine and dopamine on infectious tissue oxygen metabolism and hemodynamics in patients with shock. Shandong Medicine Journal 51: 93– 94.
Cited by
Items 201–293 of 293
Terlipressin as a first choice in septic shock—not yet
Rocha, D., Moreira, F. T., & Neto, A. S. (2019) · Journal of Thoracic Disease · doi:10.21037/jtd.2019.03.49 · Cited by 2
“did not demonstrate a decrease in mortality when comparing norepinephrine to epinephrine, dopamine, phenylephrine, or vasopressin/ terlipressin in patients with septic shock (2).”
BackgroundInfluentialExamination, Therapeutics, and Monitoring of the Cardiovascular System
Fries, R., Marr, C. M., Shih, A., Wong, D. M., & Magdesian, K. G. (2024) · Wiley eBooks · doi:10.1002/9781119617228.ch11 · Cited by 3
Song, J. H., Heo, Y. M., Oh, B. H., & Jae, H. D. (2019) · Journal of Korean Foot and Ankle Society · doi:10.14193/jkfas.2019.23.4.196 · Cited by 1
Coen, D. (2023) · Emergency Care Journal · doi:10.4081/ecj.2023.10810 · Cited by 1
Vasodilatory shock: a review of pathophysiology and vasopressor therapy
Rheingold, C. G., & Silverstein, D. C. (2024) · Companion animal · doi:10.12968/coan.2023.0072 · Cited by 1
Norepinephrine Versus Dopamine as a First-Line Vasopressor in Dogs with Hypotension: A Pilot Study
Lyons, B., Hess, R. S., & Silverstein, D. C. (2025) · Veterinary Sciences · doi:10.3390/vetsci12090832 · Cited by 1
“In human patients, NE has been associated with a survival benefit in multiple studies and is the recommended first-line vasopressor for the treatment of septic shock [10–13, 15, 22 ].”
Vasoactive drug use in children with community acquired septic shock in Australia and New Zealand
Long, E., Hearps, S. J. C., Williams, A., Gelbart, B., Butt, W., Rozen, T., McNab, S., Borland, M. L., Erickson, S., Jani, S., et al. (2025) · The Lancet Regional Health - Western Pacific · doi:10.1016/j.lanwpc.2025.101777 · Cited by 2
Cannavò, L., Capitanio, L., Beretta, V., Raitano, V., & Perrone, S. (2026) · The American Journal of Emergency Medicine · doi:10.1016/j.ajem.2026.01.035 · Cited by 1
The Management of Neonatal Sepsis and Septic Shock
Orlandin, E. A. D. S., Oharomari, L. K., & Gonçalves‐Ferri, W. A. (2026) · Current Treatment Options in Pediatrics · doi:10.1007/s40746-026-00379-3 · Cited by 2
“…(norepinephrine or epinephrine) as first-line agents, based on data showing dopamine’s association with increased arrhythmias and mortality [7, 65], and considering the use of vasopressin instead of high doses of norepinephrine, given their vasoconstrictive effects through distinct receptors…”
Acute kidney injury in children – not just for the nephrologist
Choopa, M. S., & van Biljon, G. (2015) · South African Family Practice · doi:10.4102/safp.v57i6.4376 · Cited by 1
Dopamine increases mortality in pediatric septic shock
Marik, P. E. (2015) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2015.10.073 · Cited by 1
Special Considerations for ICU Management of Patients Receiving CAR Therapy
Mahadeo, K. M., Tambaro, F. P., & Gutiérrez, C. (2019) · Elsevier eBooks · doi:10.1016/b978-0-323-66181-2.00006-8 · Cited by 1
Pereira, E. D. S., Lopes, L. D. S., & Pereira, E. D. S. (2021) · Revista Eletrônica Acervo Saúde · doi:10.25248/reas.e2818.2021 · Cited by 1
Alsunaid, S. R., & Soubani, A. O. (2023) · Springer eBooks · doi:10.1007/978-3-031-28797-8_13 · Cited by 1
Schmidt, G., Greif, I., Müller, S., Markmann, M., Edinger, F., Sander, M., Koch, C., & Henrich, M. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1401983 · Cited by 1
“However, dopamine was associated with longer intensive care unit stays, and it led to a higher rate of cardiac arrhythmias and mortality in patients with septic shock than norepinephrine (Avni et al., 2015; Ruiqiang et al., 2021; Aoki et al., 2023).”
BackgroundAdvances in vasodilatory shock: a concise review
Lahiry, S., & Ritam, R. (2019) · Journal of Analytical & Pharmaceutical Research · doi:10.15406/japlr.2019.08.00306 · Cited by 1
Alemu, E. T., Agegnehu, A. F., & Temesgen, M. M. (2020) · International Journal of Surgery Open · doi:10.1016/j.ijso.2020.11.016 · Cited by 2
Clinical Update on Vasopressors and Titration Strategies
Ragoonanan, D., & Friedman, L. (2021) · AACN Advanced Critical Care · doi:10.4037/aacnacc2021106 · Cited by 1
Bacteriemia, sepsis y shock séptico
Concha, V. M.-T., Pascual, I. P., & Moral, S. D. L. F. (2022) · Medicine - Programa de Formación Médica Continuada Acreditado · doi:10.1016/j.med.2022.02.012 · Cited by 3
Early ICU Management of Polytrauma Patients Who Develop Sepsis
Moore, F. A. (2022) · Springer eBooks · doi:10.1007/978-3-030-95906-7_34 · Cited by 1
日本版敗血症診療ガイドライン2016 CQ7:初期蘇生・循環作動薬
(2017) · Nihon Kyukyu Igakukai Zasshi Journal of Japanese Association for Acute Medicine · doi:10.1002/jja2.12184 · Cited by 1
Ramaswamy, K. N., & Singhi, S. C. (2017) · Pediatric Critical Care Medicine · doi:10.1097/pcc.0000000000001042 · Cited by 1
The Systemic Inflammatory Response Syndrome, Sepsis, and Septic Shock
Vaz, L. E., & Williams, C. N. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-75608-2.00011-2 · Cited by 1
Коновчук, В. M., & Андрущак, А. В. (2017) · Zaporozhye Medical Journal · doi:10.14739/2310-1210.2017.5.110172
Advanced Cardiovascular Support in Refractory Shock
Shetty, R. M., & Udupa, A. N. (2018) · Indian Journal of Respiratory Care · doi:10.4103/ijrc.ijrc_2_17 · Cited by 1
“Even though adrenaline may have deleterious effects on the splanchnic circulation, clinical trials do not reveal worsening of clinical outcomes.[31] However, increased aerobic lactate production through stimulation of skeletal muscle β2‐adrenergic receptors may preclude the use of lactate clearance to guide resuscitat…”
BackgroundShock and Vasopressors: State-of-the-Art Update
Kouch, M., & Dellinger, R. P. (2018) · Springer eBooks · doi:10.1007/978-3-319-94424-1_11
Outcome and Management of Sepsis at RozhHalat Emergency Hospital in Erbil –Kurdistan region of Iraq
Ahmad, S. Q., Ismaeel, S. M., Mohammed, D. A., & Ahmed, H. F. (2018) · Kurdistan Journal of Applied Research · doi:10.24017/10.24017/science.2018.2.4
Coen, D. (2019) · Springer eBooks · doi:10.1007/978-3-319-95114-0_45
Huchital, M., Au, A., & Lucido, J. V. (2019) · The Foot · doi:10.1016/j.foot.2019.08.003
CLINICAL MANIFESTATION OF LATE NEONATAL SEPSIS – CONTINU-OUS DIFFERENTIAL DIAGNOSTIC DILEMMA
Katavić, M., & Buljević, A. D. (2018) · Liječnički vjesnik · doi:10.26800/lv-141-5-6-21
Cardiovascular stress syndromes
Soeters, P. B., & de Leeuw, P. W. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-820205-0.00021-9
Marjanović, V., Budić, I., Ignjatijević, S., Stevic, M. M., & Simić, D. (2020) · Timocki medicinski glasnik · doi:10.5937/tmg2004153m
Kayaaltı, S., & Kayaaltı, Ö. (2021) · Ain-Shams Journal of Anaesthesiology · doi:10.1186/s42077-021-00132-y
“Albumin has been shown to play a critical role in a variety of diseases and has a serious effect due to its oncotic properties (Caironi and Gattinoni 2009).”
BackgroundVasopressoren: Physiologie, Pharmakologie und klinischer Einsatz
Keller, M., & Magunia, H. (2021) · AINS - Anästhesiologie · Intensivmedizin · Notfallmedizin · Schmerztherapie · doi:10.1055/a-1214-4472
“die Anwendung von Noradrenalin zu einer geringeren 28-Tage-Mortalität [12].”
BackgroundNon-adrenergic Vasopressors in Septic Shock: Overview and Update
Antonucci, E., Giovini, M., & Sakr, Y. L. (2021) · Annual update in intensive care and emergency medicine · doi:10.1007/978-3-030-73231-8_7
Lo shock settico nei primi tre mesi di vita
Crestani, S., Passini, E., Spaggiari, V., Toffoli, C., Boncompagni, A., Bedetti, L., Spaggiari, E., Lucaccioni, L., Lugli, L., Roversi, F., et al. (2021) · Medico e Bambino · doi:10.53126/meb40567
Metaraminol and Noradrenaline in Septic Shock: A Retrospective ComparisonPreprint
Krishnamohan, A., Delaney, A. P., & Gillett, M. (2021) · Research Square · doi:10.21203/rs.3.rs-934176/v1
Hemodynamic interventions and -monitoring in critically ill patients
Koster, G. (2021) · University of Groningen research database (University of Groningen / Centre for Information Technology) · doi:10.33612/diss.192215589
Protocolo terapéutico empírico de la sepsis
Concha, V. M.-T., Pintos-Pascual, I., & Parra, J. C. (2022) · Medicine - Programa de Formación Médica Continuada Acreditado · doi:10.1016/j.med.2022.02.017
Concha, V. M.-T., Pintos-Pascual, I., & Moral, S. D. L. F. (2022) · Medicine - Programa de Formación Médica Continuada Acreditado · doi:10.1016/j.med.2022.02.018
Böll, B., Kochanek, M., & Shimabukuro‐Vornhagen, A. (2018) · Elsevier eBooks · doi:10.1016/b978-3-437-15335-8.00012-2
Sepsis and the Inflammatory Response to Injury
Duchesne, J. C., & Duke, M. D. (2018) · Wiley eBooks · doi:10.1002/9781119317913.ch5
Shime, N. (2018) · Nihon Naika Gakkai Zasshi · doi:10.2169/naika.107.2252
D’Ocón, P. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.96665-0
Seifert, R. (2019) · Springer eBooks · doi:10.1007/978-3-030-18899-3_8
Sharipova, V. K., Beridze, S., Pidmurniak, O., Shanazarov, N. A., Kobeliatskyi, Y. Y., Koshlya, V. I., Peev, S. B., Babunashvili, N., Cojocaru, V., Bely, A. V., et al. (2022) · Infusion & Chemotherapy · doi:10.32902/2663-0338-2022-2-11-20 · Cited by 1
Vascular Failure and Sepsis in Pediatrics
Chidini, G., & Dona, G. (2022) · Springer eBooks · doi:10.1007/978-3-031-14612-1_9
COVID‐19: ICU and Critical Care Management
Crouch, D. J. M., Rose, A., McGuire, C., Yang, J. Z., Odish, M. F., & Bellinghausen, A. L. (2022) · Wiley eBooks · doi:10.1002/9781119789741.ch11
Clinical Management of Endotoxemia: Vasoactive and Cardiostimulant Drugs
Cocci, G., d’Errico, R., Villa, G., & Romagnoli, S. (2023) · Springer eBooks · doi:10.1007/978-3-031-18591-5_9
Pessoas inteligentes e os esportes radicais
Rodrigues, F. D. A. A. (2023) · Ciencia Latina Revista Científica Multidisciplinar · doi:10.37811/cl_rcm.v7i1.4501
Evaluation of Traumatic and Nontraumatic Patients
Kruger, V. F., & Fraga, G. P. (2023) · Springer eBooks · doi:10.1007/978-3-031-22599-4_3 · Cited by 1
Trần, T. L. T., Hoàng, T. T., Nguyễn, N. T., & Phạm, N. T. (2021) · Tạp chí Truyền nhiễm Việt Nam · doi:10.59873/vjid.v3i35.120
Resuscitation and Preparation of the Emergency General Surgery Patient
Waibel, B. H., & Kamien, A. (2023) · Surgical Clinics of North America · doi:10.1016/j.suc.2023.05.011
Rex, S., & Erber, K. (2023) · Springer Reference Medizin · doi:10.1007/978-3-642-54675-4_40-2
Estrategia integral de reanimación del paciente con sepsis y shock séptico
del Río-Carbajo, L., Olmo, J. N.-D., Fernández‐Ugidos, P., & Vidal, P. (2022) · Medicina Intensiva (English Edition) · doi:10.1016/j.medine.2022.02.025
王, 佳. (2024) · Advances in Clinical Medicine · doi:10.12677/acm.2024.142441
Relação entre os sinais vitais e as concentrações plasmáticas de óxido nítrico
Vieira, N. F. (2023) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.22.2023.tde-05022024-165008
Sepsis-Associated Acute Kidney Injury
Saraiva, I. E. B., Zaidi, S. A., Prenna, S., Marengo, M., Piscia, R., Colombatto, A., Cantaluppi, V., & Gómez, H. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-95488-4.00088-7 · Cited by 1
Acute decompensation and acute-on-chronic liver failure
Acar, Ş. (2024) · Exploration of Digestive Diseases · doi:10.37349/edd.2024.00052
Putri, A. S., Semedi, B. P., & Suryawan, I. G. R. (2024) · International Journal of Research and Review · doi:10.52403/ijrr.20240753
Rex, S., & Erber, K. (2024) · Springer Reference Medizin · doi:10.1007/978-3-662-68699-7_40
Aydın, E. G. G., Durceylan, E., Angın, Y. S., Basyazici, G., Özkara, E., Çeliksöz, A. H., Yılmaz, E., Ata, A. R., Akarsu, M., ÇINAROĞLU, A., et al. (2024) · Akademisyen Kitabevi eBooks · doi:10.37609/akya.3173
Conducta práctica ante un estado de shock séptico
Levy, M., Naudin, J., Caséris, M., Geroteo, J. S., & Dauger, S. (2024) · EMC - Pediatría · doi:10.1016/s1245-1789(24)49327-x
Efecto de los vasopresores sobre la función renal y cardíaca en pacientes con shock séptico
Daza, J. L., & Zapata-Diaz, O. E. (2024) · Acta Colombiana de Cuidado Intensivo · doi:10.1016/j.acci.2024.10.006 · Cited by 1
Microbial menace to kidney health: A review of the role of infections in acute kidney injury
Medugu, N., & Adegboro, B. (2023) · African Journal of Clinical and Experimental Microbiology · doi:10.4314/ajcem.v24i4.5
From Ambulance to Admission: A Comprehensive Analysis of EMS Vasopressor Use
Gao, H., Garcia, S., Mullan, A. F., Molinari, D. F., & Klassen, A. B. (2025) · International Journal of Paramedicine · doi:10.56068/ipna1247 · Cited by 1
Selection of Vasopressors for Sepsis-Associated Acute Kidney Injury
朱, 汝. (2025) · Advances in Clinical Medicine · doi:10.12677/acm.2025.1541194
Cardiovascular Dysfunction as a Predictor of Mortality in Children With Septic Shock
Трембач, А. В., Аleksаndrovich, Y. S., Викторович, П. В., Бгане, Н. М., Trembach, I. A., & Senicheva, D. Y. (2025) · Innovative medicine of Kuban · doi:10.35401/2541-9897-2025-10-2-63-71
Hundman, C. N., Pearson, J. G., Thomas, G. A., Jackson, C., & Burroughs‐Ray, D. (2025) · Southern Medical Journal · doi:10.14423/smj.0000000000001844
Angiotensina II en hipotensión resistente asociada a situaciones de choque
Vaca, E. R. (2025) · Panorama actual del medicamento · doi:10.63105/49.485.4
NORADRENALINE OR DOPAMINE IN SEPTIC SHOCK - A LITERATURE REVIEW
Liebert, A., Klimek, N., Wilska, H., Niedziela, A., Domoń, D., Kaplińska, M., & Domanowska, D. (2025) · International Journal of Innovative Technologies in Social Science · doi:10.31435/ijitss.3(47).2025.3552
Low-Dose Dopamine in Early Renal Dysfunction: The ANZICS Dopamine Trial
Chacko, J., Chalfin, D. B., Seppelt, I., Pawar, S., & Brar, G. (2025) · Springer eBooks · doi:10.1007/978-981-95-0673-6_34
Early Mortality Prediction in Adult Sepsis Patients Using the Vasoactive-Inotropic Score
Sun, Q.-Z., Li, S.-C., & Zhao, J. (2021) · Bulletin of pioneering researches of medical and clinical science · doi:10.51847/omr5or5vzg
Shields, L. E., & Lin, S. N. (2025) · Obstetrics and Gynecology Clinics of North America · doi:10.1016/j.ogc.2025.09.004
Buensalido, J. A. L., Malundo, A. F. G., Aherrera, J. A. M., Magno, J. D. A., Maramara, M. K. P., Punzalan, F. E. R., Tolosa, M. T. S., Briones, G., Hernandez, A. M. R., Pantaleon, A. F., et al. (2022) · Philippine Journal of Internal Medicine · doi:10.65564/pjim.10a45be121
Ressuscitação Hemodinâmica Guiada por Metas na Sepse: Revisão Narrativa de Literatura
Gomes, L. C., & Cardoso, K. M. (2026) · Brazilian Journal of Implantology and Health Sciences · doi:10.36557/2674-8169.2026v8n1p53-69
Current evidence on septic shock in patients with cirrhosis
Serafim, L. P., & de Moraes, A. G. (2026) · Current Opinion in Critical Care · doi:10.1097/mcc.0000000000001372
Physiologie und Pathophysiologie des Neugeborenen
Bührer, C. (2026) · Springer Reference Medizin · doi:10.1007/978-3-662-53390-1_1-2
Uddin, A., Uddin, M. S., Dhedhi, H. A. A., Tahir, M., Sajjad, A., Shafiq, S. S., Shakeel, R., & Uddin, A. A. (2026) · Research Square · doi:10.21203/rs.3.rs-9005126/v1
Utility of a Peripheral Intravenous Catheter for Administration of Vasopressors: A Narrative Review
Ashraf, M. H., Dasan, S. L. A. M., Zacharia, G. S., Ali, M., Hocine, F. K., Mazhar, N., Yordanka, D. S., & Khaja, M. (2026) · Cureus · doi:10.7759/cureus.105205
Lissnyder, N. D., Muscato, C. Y., & Honoré, P. M. (2026) · Critical Care Medicine · doi:10.1097/ccm.0000000000007015
He, Y., Zhang, X., Wang, T., Fang, X., Sun, N., Zhang, J., Li, Y., Tacke, F., Zhang, W., Gao, Y., et al. (2026) · Expert Review of Clinical Pharmacology · doi:10.1080/17512433.2026.2679596
Optimizing Timing and Dose of Starting Norepinephrine and Vasopressin in Septic Shock
Hiroto, G., Nishikimi, M., & Shime, N. (2026) · Life · doi:10.3390/life16060913
“…superiority of NE has not been completely established [15,16]; however, findings from multiple systematic reviews and meta-analyses have consistently indicated that NE has a more favorable safety profile, thereby supporting its preferential use as the first-line vasopressor in septic shock [17,18].”
Martin, M. M., de Oliveira, J. E., Silva, P. E. G., de Queiroz, S. S., dos Santos, T. A., Barbosa, D. A., da Fonseca, C. D., & Miura, C. R. M. (2026) · Revista Brasileira de Enfermagem · doi:10.1590/0034-7167-2025-0141
“Studies show that VAD use among COVID-19 patients treated in the ICU ranges from 28% to 94% (28,29) , norepinephrine being the first-line vasopressor, and vasopressin, the second-line agent, as evidenced in the clinical management of the sample studied (30,31) .”
RAMIREZ, F., & Rodriguez, J. D. A. (2026) · IECCMEXICO · doi:10.64784/224
Geroteo, J. S., Dauger, S., & Levy, M. (2026) · EMC - Médecine d urgence · doi:10.1016/s1959-5182(26)41791-2
Girard, W. S., Turkistani, F., Kakande, R., Adejayan, V., Zulfiqar, M., Ndyomugabe, M., Gruccio, P., Ojuman, P., Otoupalova, E., Banguti, P., et al. (2026) · Critical Care Explorations · doi:10.1097/cce.0000000000001481 · Cited by 1
“However, use of norepinephrine in patients with hypotension leads to lower mortality and lower risk of arrhythmias compared with dopamine (33).”
Management of abdominal sepsis: Principles, pitfalls, and perspectives
Sartelli, M. (2026) · Intensive Care Science · doi:10.1016/j.iics.2026.08.004
Therapeutic and Biomedical Applications of Dopamine‐Derived Scaffolds: A Comprehensive Review
Kaboudin, B., & Barati, A. (2026) · ChemMedChem · doi:10.1002/cmdc.70547
“Norepinephrine and epinephrine, by stimulating cardiac α 1 and β receptors, are first-line vasopressors for septic and cardiogenic shock, providing combined inotropic and vasopressor support [24].”
Metadata
- Authors
- Avni, T., Lador, A., Lev, S., Leibovici, L., Paul, M., & Grossman, A.
- Affiliations
- Tel Aviv University (IL)
- Technion – Israel Institute of Technology (IL)
- Corresponding author
- Avni, Tomer
- Venue
- PLOS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2015-08-03
- Volume
- 10
- Issue
- 8
- Pages
- e0129305
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC4523170
- OpenAlex
- W1630391490
- Cited by
- 293
- References
- 48
- Citations by year
- 2026: 19 · 2025: 24 · 2024: 33 · 2023: 26 · 2022: 29 · 2021: 37 · 2020: 30 · 2019: 34 · 2018: 29 · 2017: 17 · 2016: 11 · 2015: 3
- FWCI
- 2.60
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- PLoS ONE (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- Topics
- Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Sepsis Diagnosis and Treatment
- Health Sciences › Medicine › Surgery › Hemodynamic Monitoring and Therapy
- Health Sciences › Medicine › Surgery › Abdominal Surgery and Complications
- Keywords
- septic shock, vasopressors, norepinephrine, dopamine, phenylephrine, epinephrine, vasopressin, terlipressin, all-cause mortality, hemodynamic outcomes, cardiac arrhythmias, blood lactate
- MeSH terms
- Terlipressin, Epinephrine, Hemodynamics, Humans, Lypressin, Norepinephrine, Phenylephrine, Shock, Septic, Vasoconstrictor Agents, Vasopressins, Treatment Outcome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.